Company Overview of Velcura Therapeutics Inc.
Velcura Therapeutics, Inc., a bone disease biotechnology company, develops therapies to restore bone homeostasis and bone health. It develops therapies for the treatment of bone diseases, such as rheumatoid arthritis, multiple myeloma, bone metastases, and osteoporosis. Velcura Therapeutics, Inc. has a strategic partnership with Nippon Chemiphar Co., Ltd. Velcura Therapeutics, Inc. was formerly known as Osteomics Inc. The company was founded in 2001 and is based in Ann Arbor, Michigan.
4300 Varsity Drive
Ann Arbor, MI 48108
Founded in 2001
Key Executives for Velcura Therapeutics Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Velcura Therapeutics Inc., please visit www.velcura.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.